|
|
Latest Story |
AMGEN PRESENTS NEW RESEARCH ON OTEZLA(R) (APREMILAST) AT AAD 2024 |
PR Newswire |
SPROUT 52-Week Data Demonstrate Durable Response and Consistent Safety Profile of Oral Otezla in Children with Moderate to Severe Plaque Psoriasis Late-Breaking Phase 3 Study of Otezla in Palmoplantar Pustulosis Achieves Primary and Secondary Endpoints at 16 Weeks |
Full Story → |
Headline News |
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND |
4:00p ET March 6 '24 PR Newswire |
AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE |
9:51a ET March 5 '24 PR Newswire |
AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO |
9:00a ET February 26 '24 PR Newswire |
More News → |
|
April 19 '24. Markets Closed. | ||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||
Previous data from yesterday, April 18 '24. |